Skip to Content

Acamprosate Calcium Tablets

Last Updated: December 16, 2015
Status: Resolved

Products Affected - Description

All presentations are currently available

Reason for the Shortage

  • Glenmark Pharmaceuticals could not provide a reason for the shortage.
  • Mylan could not provide a reason for the shortage.
  • Actavis discontinued Campral tablets in 2014.

Available Products

Acamprosate calcium oral tablet, Glenmark
333 mg tablets, 180 count (NDC 68462-0435-18)

 
Acamprosate calcium oral tablet, Mylan
333 mg, bottle, 180 count (NDC 00378-6333-80)
 
Acamprosate calcium oral tablet, Mylan Institutional
333 mg, unit-dose 50 count (NDC 51079-0241-06)

Estimated Resupply Dates

All presentations are currently available.

Related Shortages

Updated

December 16 and 1, October 29, September 3, July 9, June 2, May 21 and 6, March 30, February 27, January 30, 2015, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide